Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2020-04-16 Director's Dealing
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2020-04-16 English
4 Filing
Director's Dealing
2020-04-14 English
4 Filing
Director's Dealing
2020-04-14 English
4 Filing
Director's Dealing
2020-04-14 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Moderna, Inc. It includes a press release about interim Phase 1 data from a vaccine candidate and mentions a webcast event. The document explicitly states that the press release is attached as an exhibit and that the webcast information is not part of the filing. The document is relatively short (3771 characters) and primarily serves to announce the press release and webcast event rather than providing detailed financial data or comprehensive reporting. There are no financial statements or substantive financial analysis included. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Earnings Release or Interim Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-04-14 English
4 Filing
Director's Dealing
2020-04-08 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.